Kuldeep Singh Rajput is the CEO and Founder of Biofourmis, a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives. Biofourmis is pioneering an entirely new category of digital health, by developing clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Recognized as the "Forbes 30 Under 30", Kuldeep has demonstrated strong leadership experience with building teams, developing talents, and successfully growing, and managing strategic partnerships with global pharmaceutical manufacturers, health systems and Payers. Under his leadership, Biofourmis has raised over $45 Million in venture capital from leading Venture Capital firms including Sequoia Capital, MassMutual Ventures, Aviva plc, and Mayo Clinic Ventures. He uses his background and experience in biomedical engineering and data from the Massachusetts Institute of Technology (MIT) to unfold his vision of "Predicting and Preventing Serious Medical Events using AI".